Intellia Therapeutics Q4 EPS $(0.83) Beats $(0.96) Estimate, Sales $23.017M Beat $12.812M Estimate
Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate of $(0.96) by 13.72 percent. This is a 34.65 percent increase over losses of $(1.27) per share
